{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:14:08Z","timestamp":1790727248435,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009764","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000}}],"reference-count":77,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009764.pub2","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T15:01:34Z","timestamp":1385650894000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)"],"prefix":"10.1002","author":[{"given":"Samantha C","family":"Herath","sequence":"first","affiliation":[{"name":"431 Glebe Point Road; Woolcock Institute of Medical Research; Sydney New South Wales Australia 2037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillippa","family":"Poole","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Medicine; Private Bag 92019 Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,11,28]]},"reference":[{"key":"10.1002\/14651858.CD009764.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.rmed.2004.06.009","article-title":"The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD","volume":"99","author":"Banerjee","year":"2005","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000321374","article-title":"Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease","volume":"80","author":"He","year":"2010","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0004|cit4","unstructured":"Mygind LH Pedersen C Vestbo J Christensen JJ Frimodt-Moller N Kristiansen IS A randomised, placebo-controlled 3 years study of prophylactic azithromycin in 575 patients with chronic obstructive pulmonary disease European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona Barcelona, Spain 2010"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: A randomized control trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.120.3.730","article-title":"Erythromycin and common cold in COPD","volume":"120","author":"Suzuki","year":"2001","journal-title":"Chest"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00151829-200403010-00007","article-title":"The effect of oral Clarithromycin on bronchial airway inflammation in moderate -to-severe stable COPD: A randomised controlled trial","volume":"3","author":"Banerjee","year":"2004","journal-title":"Treatments in Respiratory Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0009|cit9","first-page":"642","article-title":"Trial of preventive treatment of patients with chronic bronchitis","volume":"37","author":"Beier","year":"1971","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pupt.2009.12.002","article-title":"Long term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy","volume":"23","author":"Blasi","year":"2010","journal-title":"Pulmonary Pharmacology and Theraputics"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0011|cit11","first-page":"483","article-title":"Prophylactic administration of Bactrim in chronic bronchitis","volume":"5-6","author":"Bruninx","year":"1973","journal-title":"Acta Tuberculosea et Pneumologica Belgica"},{"issue":"7049","key":"10.1002\/14651858.CD009764.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(58)91334-5","article-title":"Long term prophylactic administration of tetracycline to chronic bronchitis","volume":"2","author":"Buchanan","year":"1958","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD009764.pub2-BIB0013|cit13","first-page":"351","article-title":"Assessment if chemoprophylaxis with intermittent tetracycline in chronic-bronchitis - a functional follow-up for 3 years","volume":"8","author":"Bussi","year":"1980","journal-title":"Revue Francaise des Maladies Respiratoires"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0007-0971(68)80040-3","article-title":"A five year study of bacteriology and prophylactic chemotherapy in patients with chronic bronchitis","volume":"62","author":"Calder","year":"1968","journal-title":"British Journal of Diseases of the Chest"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(61)90125-5","article-title":"Bacterial Infection and some effects of chemoprophylaxis in chronic pulmonary emphysema","volume":"31","author":"Davies","year":"1961","journal-title":"American Journal of Medicine"},{"issue":"6988","key":"10.1002\/14651858.CD009764.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(57)91597-0","article-title":"Effect of antibiotics on purulent sputum","volume":"273","author":"Douglas","year":"1957","journal-title":"Lancet"},{"issue":"5103","key":"10.1002\/14651858.CD009764.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bmj.2.5103.1010","article-title":"Adult chronic bronchitis-continuous antibiotic therapy","volume":"2","author":"Edwards","year":"1958","journal-title":"British Medical Journal"},{"issue":"5056","key":"10.1002\/14651858.CD009764.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/bmj.2.5056.1272","article-title":"Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis","volume":"2","author":"Elmes","year":"1957","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.1.5499.1317","article-title":"Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the Medical Research Council by their working party on trials of chemotherapy in early chronic bronchitis","volume":"1","author":"Fletcher","year":"1966","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/bmj.1.5385.728","article-title":"Influence of daily penicillin, tetracycline, erythromycin and sulphamethoxypyridazine on exacerbation of bronchitis","volume":"1","author":"Frances","year":"1964","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bmj.1.5169.297","article-title":"Chemotherapy in chronic bronchitis.Influence of daily penicillin and tetracycline on exacerbations and their cost","volume":"30","author":"Francis","year":"1960","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD009764.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.52.3.376","article-title":"Continous suppressive antimicrobial treatment in chronic infected bronchitis during winter months","volume":"52","author":"Goslings","year":"1967","journal-title":"Disease of the Chest"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1378\/chest.113.1.131","article-title":"A 1-year community based health economic study of ciprofloxacin treatment in acute exacerbations of chronic bronchitis: The Canadian Ciprofloxacin Health Economics Study Group","volume":"113","author":"Grossman","year":"1998","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/AAC.2.1.45","article-title":"Ampicillin and tetracyclin in the treatment and prophylaxis of chronic bronchitis","volume":"2","author":"Hahn","year":"1972","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0025|cit25","first-page":"716","article-title":"Chemoprophylaxis in chronic obstructive pulmonary emphysema","volume":"80","author":"Hallet","year":"1959","journal-title":"Chemoprophylaxis in Emphysema"},{"issue":"6839","key":"10.1002\/14651858.CD009764.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(56)91240-5","article-title":"Long-term oxytetracycline (Terramycin) therapy in advanced chronic respiratory infections","volume":"267","author":"Helm","year":"1956","journal-title":"Lancet"},{"issue":"5258","key":"10.1002\/14651858.CD009764.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/bmj.2.5258.985","article-title":"A trial of phenethicillin in chronic bronchitis","volume":"2","author":"Johnston","year":"1961","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.4.5678.265","article-title":"Five year winter prophylaxis for chronic bronchitis","volume":"4","author":"Johnston","year":"1969","journal-title":"British Medical Journal"},{"issue":"4884","key":"10.1002\/14651858.CD009764.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.2.4884.385","article-title":"Sulphonmide prophylaxis in chronic bronchitis","volume":"2","author":"Kilpatrick","year":"1954","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0030|cit30","first-page":"883","article-title":"Double blind long term study on a combination of tetracycline, theophylline, doxylamine succinate , etafedrine, phenylephedrine and guaifenesine in chronic bronchitis","volume":"27","author":"Legler","year":"1977","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0954-6820.1987.tb01280.x","article-title":"Trimethoprim prophylaxis of acute exacerbations in chronic obstructive pulmonary disease","volume":"221","author":"Liippo","year":"1987","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1753465810368552","article-title":"Prophylactic antibiotic therapy in chronic obstructive pulmonary disease","volume":"4","author":"Maraffi","year":"2010","journal-title":"Theraputic Advances in Respiratory Disease"},{"issue":"6947","key":"10.1002\/14651858.CD009764.pub2-BIB0033|cit33","first-page":"814","article-title":"Long term chemotherapy in chronic bronchitis","volume":"271","author":"May","year":"1956","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1183\/09031936.00195608","article-title":"Efficacy of Moxifloxacin in the treatment of bronchial colonisation in COPD","volume":"34","author":"Miravitlles","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0041-3879(59)80150-1","article-title":"Prophylactic chemotherapy in chronic bronchitis","volume":"40","author":"Moyes","year":"1959","journal-title":"Tubercle"},{"issue":"5162","key":"10.1002\/14651858.CD009764.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bmj.2.5162.1277","article-title":"An evaluation of continuous antibiotic therapy in chronic bronchitis","volume":"2","author":"Murdoch","year":"1959","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0037|cit37","first-page":"244","article-title":"A trial of ampicillin in chronic bronchitis","volume":"7","author":"Murray","year":"1964","journal-title":"The Journal of the College of General Practitioners"},{"issue":"11","key":"10.1002\/14651858.CD009764.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jama.1962.03050110001001","article-title":"Long term tetracycline treatment of chronic bronchitis","volume":"179","author":"Norman","year":"1962","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/bmj.3.5559.202","article-title":"Controlled trials of a sulphonamide given weekly to prevent exacerbations of chronic bronchitis","volume":"3","author":"Pines","year":"1967","journal-title":"British Medical Journal"},{"issue":"7153","key":"10.1002\/14651858.CD009764.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(60)91792-X","article-title":"A trial of continuous winter chemotherapy in chronic bronchitis","volume":"2","author":"Pridie","year":"1960","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0041|cit41","first-page":"955","article-title":"Chemoprophylaxis with erythromycin stearate or amoxacillin in patients with chronic bronchitis-effects on cellular and humoral immune functions","volume":"66","author":"Ras","year":"1984","journal-title":"South African Medical Journal"},{"issue":"10","key":"10.1002\/14651858.CD009764.pub2-BIB0042|cit42","first-page":"1194","article-title":"A well-controlled comparative clinical study of the combination regimen of ciprofloxacin plus erythromycin for the treatment of repeated acute exacerbations of chronic respiratory tract infections","volume":"42","author":"Watanabe","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00019053-199916050-00007","article-title":"Economic evaluation of ciprofloxacin compared with usual anti-bacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year","volume":"16","author":"Torrance","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0007-0971(70)80050-X","article-title":"Prevention of exacerbations of bronchitis: trial of a long acting sulphonamide","volume":"64","author":"Vandenbergh","year":"1970","journal-title":"British Journal of Diseases of the Chest"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1007\/BF01715833","article-title":"Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease","volume":"19","author":"Watanabe","year":"1991","journal-title":"Infection"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0046|cit46","first-page":"1194","article-title":"A well controlled comparative clinical study of the combination regimen of ciprofloxacin plus erythromycin","volume":"42","author":"Watanabe","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.176.25","article-title":"Daily single-dose regimen and alternate two-week triple dose\/day regimen of oral ofloxacin for the prophylaxis and control of exacerbations of chronic respiratory tract infections","volume":"176","author":"Watanabe","year":"1995","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/thx.26.3.319","article-title":"A double blind cross-over trail of trimethoprim and sulphamethoxazole in chronic bronchitis","volume":"26","author":"Webster","year":"1971","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Uzun S Djamin R Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD www.ClinicalTrials.gov 2012","DOI":"10.1186\/1745-6215-13-82"},{"issue":"5","key":"10.1002\/14651858.CD009764.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1064-71","DOI":"10.1183\/09031936.97.10051064","article-title":"Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project","volume":"10","author":"Anderson","year":"1997","journal-title":"European Respiratory Journal"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD009764.pub2-BIB0051|cit51","first-page":"43S-52S","article-title":"Epidemiology and treatment of chronic bronchitis and its exacerbations","volume":"108","author":"Ball","year":"1995","journal-title":"Chest"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.rmed.2004.06.009","article-title":"The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD","volume":"99","author":"Banerjee","year":"2005","journal-title":"Respiratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD009764.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD009764.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002309.pub3","article-title":"Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease","author":"Chong","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0055|cit55","unstructured":"Global Initiative for Chronic Obstructive Lung Disease http:\/\/www.goldcopd.com [Accessed 23rd November 2012]"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.42.10.773","article-title":"A measure of quality of life for clinical trials in chronic lung disease","volume":"42","author":"Guyatt","year":"1987","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-126-9-199705010-00007","article-title":"Using numerical results from systematic reviews in clinical practice","volume":"126","author":"McQuay","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0058|cit58","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0060|cit60","unstructured":"Jones P St George's Respiratory Questionnaire Manual Version 2.3 2009 1 16"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11606-007-0118-3","article-title":"Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma","volume":"22","author":"Lee","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","article-title":"Global burden of COPD: risk factors, prevalence, and future trends","volume":"370","author":"Mannino","year":"2007","journal-title":"Lancet"},{"issue":"4 pt 1","key":"10.1002\/14651858.CD009764.pub2-BIB0063|cit63","first-page":"1316-20","article-title":"Bacterial infection in chronic obstructive pulmonary disease: a study of stable and exacerbated outpatients using the protected specimen brush","volume":"152","author":"Mons\u00f3","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0064|cit64","unstructured":"NCT00985244 Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00985244"},{"issue":"8","key":"10.1002\/14651858.CD009764.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001287.pub4","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0066|cit66","unstructured":"Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration Review Manager (RevMan) Version 5.1 2008"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1498-505","DOI":"10.1164\/ajrccm.157.5.9711044","article-title":"Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation","volume":"157","author":"Soler","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004105","article-title":"Prophylactic antibiotic therapy for chronic bronchitis","author":"Staykova","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009764.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"701-5","DOI":"10.1093\/oxfordjournals.aje.a116730","article-title":"Air pollution and emergency room admission for chronic obstructive pulmonary disease: A 5-year study","volume":"137","author":"Sunyer","year":"1993","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD009764.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.2005.041822","article-title":"COPD exacerbations \u00b7 2: Aetiology","volume":"61","author":"Sapey","year":"2006","journal-title":"Thorax"},{"issue":"144","key":"10.1002\/14651858.CD009764.pub2-BIB0071|cit71","first-page":"149","article-title":"Impact of salmeterol\/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease","volume":"175","author":"Kardos","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0072|cit72","unstructured":"A document produced for the Thoracic Society of Australia and New Zealand (New Zealand Branch) Standards for adult respiratory and sleep services in New Zealand www.moh.govt.nz"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0074|cit74","unstructured":"Visual Rx www.nntonline.net\/visualrx\/ Accessed October 2013"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2710.2011.01285.x","article-title":"Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis","volume":"37","author":"Wang","year":"2012","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009764.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMct1115170","article-title":"Antibiotic prevention of acute exacerbations of COPD","volume":"367","author":"Wenzel","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009764.pub2-BIB0077|cit77","unstructured":"World Health Organization Chronic obstructive pulmonary disease http:\/\/www.who.int\/respiratory\/copd\/en\/"}],"updated-by":[{"DOI":"10.1002\/14651858.cd009764.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009764.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:36:34Z","timestamp":1628534194000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD009764.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":77,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009764.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718190843.793489147","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,28]]}}}